We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The firm failed to demonstrate that the active pharmaceutical ingredients could be deactivated and removed from surfaces located in laboratories that are not dedicated to the manufacturing.